Chemical sensors for the early diagnosis of bacterial resistance to β-lactam antibiotics
Loading...
Identifiers
ISSN: 0045-2068
E-ISSN: 1090-2120
Publication date
Advisors
Tutors
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Abstract
β-Lactamases are bacterial enzymes that inactivate β-lactam antibiotics and, as such, are the most prevalent cause of antibiotic resistance in Gram-negative bacteria. The ever-increasing production and worldwide dissemination of bacterial strains producing carbapenemases is currently a global health concern. These enzymes catalyze the hydrolysis of carbapenems – the β-lactam antibiotics with the broadest spectrum of activity that are often considered as drugs of last resort. The incidence of carbapenem-resistant pathogens such as Pseudomonas aeruginosa, Acinetobacter baumannii and carbapenemase or extended spectrum beta-lactamase (ESBL)-producing Enterobacterales, which are frequent in clinical settings, is worrisome since, in some cases, no therapies are available. These include all metallo-β-lactamases (VIM, IMP, NDM, SMP, and L1), and serine-carbapenemases of classes A (KPC, SME, IMI, and GES), and of classes D (OXA-23, OXA-24/40, OXA-48 and OXA-58). Consequently, the early diagnosis of bacterial strains harboring carbapenemases is a pivotal task in clinical microbiology in order to track antibiotic bacterial resistance and to improve the worldwide management of infectious diseases. Recent research efforts on the development of chromogenic and fluorescent chemical sensors for the specific and sensitive detection and quantification of β-lactamase production in multidrug-resistant pathogens are summarized herein. Studies to circumvent the main limitations of the phenotypic and molecular methods are discussed. Recently reported chromogenic and fluorogenic cephalosporin- and carbapenem-based β-lactamase substrates will be reviewed as alternative options to the currently available nitrocefin and related compounds, a chromogenic cephalosporin-based reagent widely used in clinical microbiology laboratories. The scope of these new chemical sensors, along with the synthetic approaches to synthesize them, is also summarized
Description
Bibliographic citation
Bioorganic Chemistry 150 (2024) 107528
Relation
Has part
Has version
Is based on
Is part of
Is referenced by
Is version of
Requires
Publisher version
https://doi.org/10.1016/j.bioorg.2024.107528Sponsors
This work was funded by the Spanish State Agency of Research (PID2022-136963OB I00/AEI/10.13039/501100011033, CG-B), the Xunta de Galicia [ED431C 2021/29 and Centro singular de investigación de Galicia accreditation 2023-2027 (ED431G 2023/03), CG-B], and the European Regional Development Fund (ERDF). We thank Dr. Jorge Arca-Suárez for helpful discussions on writing this manuscript
Rights
Attribution-NonCommercial-NoDerivatives 4.0 Internacional
© 2024 The Author(s). Published by Elsevier Inc. This article is available under the Creative Commons CC-BY-NC-ND license
© 2024 The Author(s). Published by Elsevier Inc. This article is available under the Creative Commons CC-BY-NC-ND license








